Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 6

Optimizing management of chronic obstructive pulmonary disease in the upcoming decade

Authors Russell R, Anzueto A, Weisman I

Published 10 January 2011 Volume 2011:6 Pages 47—61


Review by Single anonymous peer review

Peer reviewer comments 3

Download Article [PDF] 

Richard Russell1, Antonio Anzueto2, Idelle Weisman3
1Department of Thoracic Medicine, National Heart and Lung Institute, Imperial College, London, UK; 2University of Texas Health Science Center at San Antonio, South Texas Veterans Health Care System, San Antonio, Texas, USA; 3Pfizer Inc, Medical Affairs, Respiratory, Primary Care Business Unit, New York, USA

Abstract: Chronic obstructive pulmonary disease (COPD) is a leading cause of disability and mortality. Caring for patients with COPD, particularly those with advanced disease who experience frequent exacerbations, places a significant burden on health care budgets, and there is a global need to reduce the financial and personal burden of COPD. Evolving scientific evidence on the natural history and clinical course of COPD has fuelled a fundamental shift in our approach to the disease. The emergence of data highlighting the heterogeneity in rate of lung function decline has altered our perception of disease progression in COPD and our understanding of appropriate strategies for the management of stable disease. These data have demonstrated that early, effective, and prolonged bronchodilation has the potential to slow the rate of decline in lung function and to reduce the frequency of exacerbations that contribute to functional decline. The goals of therapy for COPD are no longer confined to controlling symptoms, reducing exacerbations, and maintaining quality of life, and slowing disease progression is now becoming an achievable aim. A challenge for the future will be to capitalize on these observations by improving the identification and diagnosis of patients with COPD early in the course of their disease, so that effective interventions can be introduced before the more advanced, disabling, and costly stages of the disease. Here we critically review emerging data that underpin the advances in our understanding of the clinical course and management of COPD, and evaluate both current and emerging pharmacologic options for effective maintenance treatment.

Keywords: COPD, chronic obstructive pulmonary disease, long-acting bronchodilator, early treatment

A Letter to the Editor has been received and published for this article.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]